Senescence as a pathogenic driver in chronic kidney disease: From cellular fate to clinical stratification DOI Creative Commons
Samuel D. Chauvin,

Anne Coutrot,

Camille Cohen

et al.

Clinical and Translational Discovery, Journal Year: 2025, Volume and Issue: 5(3)

Published: May 19, 2025

Language: Английский

Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways DOI Creative Commons
Bowei Liu, Zhigang Peng, Hao Zhang

et al.

Molecular Cancer, Journal Year: 2025, Volume and Issue: 24(1)

Published: April 2, 2025

Cellular senescence, a stable state of cell cycle arrest induced by various stressors or genomic damage, is recognized as hallmark cancer. It exerts context-dependent dual role in cancer initiation and progression, functioning tumor suppressor promoter. The complexity senescence arises from its mechanistic diversity, potential reversibility, heterogeneity. A key mediator these effects the senescence-associated secretory phenotype (SASP), repertoire bioactive molecules that influence microenvironment (TME) remodeling, modulate behavior, contribute to therapeutic resistance. Given intricate biology, presents both challenges opportunities for intervention. Strategies targeting pathways, including senescence-inducing therapies senolytic approaches, offer promising avenues treatment. This review provides comprehensive analysis regulatory mechanisms governing cellular tumors. We also discuss emerging strategies highlighting novel opportunities. deeper understanding processes essential developing precision improving clinical outcomes.

Language: Английский

Citations

3

Non-coding RNAs participate in interactions between senescence and gastrointestinal cancers DOI Creative Commons
Zhaozhe Liu,

Fa-He Ji,

Ying Piao

et al.

Frontiers in Genetics, Journal Year: 2025, Volume and Issue: 15

Published: Jan. 3, 2025

Relationships between cellular senescence and gastrointestinal cancers have gained prominence in recent years. The currently accepted theory suggests that cancer occurrence exhibit "double-edged sword" effects. Cellular is related to via four "meta-hallmarks" i.e., genomic instability, epigenetic alterations, chronic inflammation, dysbiosis, along with two "antagonistic hallmarks" telomere attrition stem cell exhaustion. These relationships are characterized by both agonistic antagonistic elements, but the existence of an intricate dynamic balance remains unknown. Non-coding RNAs (ncRNAs) vital roles post-transcriptional regulation, how they participate be fully investigated. In this article, we systematically review ncRNAs (including microRNAs (miRNAs), long (lncRNAs), circularRNAs (circRNAs)) interactions cancers. Our aim elucidate a triangular relationship "ncRNAs-senescence-gastrointestinal cancers" which considered these three elements as equal important standing. We keen identify prognostic or therapeutic targets for from, aging-related ncRNAs, discover novel strategies treat manage elderly. seek clarify complex where "senescence-gastrointestinal interactions.

Language: Английский

Citations

0

Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging DOI
Hui Fang,

Eunsun Yu,

Chang Liu

et al.

Seminars in Cancer Biology, Journal Year: 2025, Volume and Issue: 111, P. 1 - 15

Published: Feb. 9, 2025

Language: Английский

Citations

0

Comparative analysis of senescence induction by different chemotherapeutic agents in HCT116 colon cancer cells DOI

Adrien Pioger,

Ingrid Loison,

Inès Metatla

et al.

Biochemical and Biophysical Research Communications, Journal Year: 2025, Volume and Issue: 752, P. 151482 - 151482

Published: Feb. 11, 2025

Language: Английский

Citations

0

A Novel Platform for Precise Senolysis DOI

Conti Anastasia,

Di Micco Raffaella

Mechanisms of Ageing and Development, Journal Year: 2025, Volume and Issue: unknown, P. 112056 - 112056

Published: April 1, 2025

Language: Английский

Citations

0

Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics? DOI Creative Commons
Zhihong Yang, Duilio Michele Potenza, Xiu‐Fen Ming

et al.

Biomolecules, Journal Year: 2025, Volume and Issue: 15(4), P. 545 - 545

Published: April 8, 2025

Aging is a predominant risk factor for cardiovascular diseases. There evidence demonstrating that senescent cells not only play significant role in organism aging but also contribute to the pathogenesis of diseases younger ages. Encouraged by recent findings elimination pharmacogenetic tools could slow down and even reverse animal models, senolytic drugs have been developed, translation results from basic research clinical settings has initiated. Because numerous studies literature show beneficial therapeutic effects targeting cardiomyopathies associated with ischemia/reperfusion atherosclerotic vascular disease, are considered next generation therapies disorders. However, reported controversial or detrimental caused approaches, including worsening cardiac dysfunction, instability plaques, an increase mortality which challenges therapy into practice. This brief review article will focus on (1) analyzing discussing approaches (2) future directions questions essential understand controversies translate preclinical

Language: Английский

Citations

0

Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases DOI Creative Commons

P. W. Yu,

Bin Liu, Cheng Dong

et al.

Cells, Journal Year: 2025, Volume and Issue: 14(8), P. 619 - 619

Published: April 21, 2025

A significant increase in life expectancy worldwide has resulted a growing aging population, accompanied by rise aging-related diseases that pose substantial societal, economic, and medical challenges. This trend prompted extensive efforts within many scientific communities to develop enhance therapies aimed at delaying processes, mitigating functional decline, addressing aging-associated extend health span. Research biology focused on unraveling various biochemical genetic pathways contributing changes, including genomic instability, telomere shortening, cellular senescence. The advent of induced pluripotent stem cells (iPSCs), derived through reprogramming human somatic cells, revolutionized disease modeling understanding humans the limitations conventional animal models primary cells. iPSCs offer advantages over other such as embryonic they can be obtained without need for embryo destruction are not restricted availability healthy donors or patients. These attributes position iPSC technology promising avenue deciphering mechanisms underlie associated diseases, well studying drug effects. Moreover, exhibit remarkable versatility differentiating into diverse cell types, making them tool personalized regenerative replacing aged damaged with healthy, equivalents. review explores breadth research iPSC-based their potential applications spectrum conditions.

Language: Английский

Citations

0

Impact of radiation therapy on the immunological tumor microenvironment DOI
Emma Guilbaud,

Flavie Naulin,

Lydia Meziani

et al.

Cell chemical biology, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0

HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells DOI Creative Commons
Víctor Casanova,

Andrea Rodríguez-Agustín,

Rubén Ayala-Suárez

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: April 24, 2025

Current antiretroviral therapy (ART) for HIV infection reduces plasma viral loads to undetectable levels and has increased the life expectancy of people with (PWH). However, this lifespan is accompanied by signs accelerated aging a higher prevalence age-related comorbidities. Tat (Trans-Activator Transcription) key protein replication pathogenesis. encoded 2 exons, full-length ranging from 86 101 aa (Tat101). Introducing stop codon in position 73 generates 1 exon, synthetic 72aa (Tat72). Intracellular, activates NF-κB pro-inflammatory pathway increases antiapoptotic signals ROS generation. These effects may initiate cellular senescence program, characterized cell cycle arrest, altered metabolism, senescence-associated secretory phenotype (SASP) mediator release precise role HIV-Tat inducing program CD4+ T-cells currently unknown. Jurkat Tetoff lines stably transfected Tat72, Tat101, or an empty vector were used. Flow cytometry RT-qPCR used address biomarkers, 105 mediators assessed supernatants antibody-based membrane array. Key results obtained Jurkat-Tat cells addressed primary, resting transient electroporation HIV-Tat-FLAG plasmid DNA. In model, expression Tat101 biomarkers BCL-2, CD87, p21, sCD30, PDGF-AA, sCD31, among other factors. upregulated CD30 CD31 co-expression surface, distinguishing these Tat72 Jurkats. The percentage p21+, p16+, γ-H2AX+ Tat-expressing T-cells, detected as FLAG+ population compared their FLAG- (Tat negative) counterparts. Increased sCD31 sCD26 also electroporated T-cell supernatants. several SASP/Aging Intracellular contributing premature observed PWH.

Language: Английский

Citations

0

Trilocked Photodynamic Senolytic Inducer Potentiating Immunogenic Senescent Cell Removal for Liver Fibrosis Resolution DOI
Pei Lu, Huihui Zhou, Xiaoxiao Xu

et al.

Journal of the American Chemical Society, Journal Year: 2025, Volume and Issue: unknown

Published: April 30, 2025

Liver fibrosis is a major global health problem without effective therapies, and targeted elimination of senescent cells beneficial for hepatic function organism survival. We report new trilocked photodynamic senolytic inducer (PDSI) strategy liver resolution using type-I agent immunogenic clearance cells. demonstrate that this PDSI not only facilitates efficient production superoxide anions (O2•-) in lysosomes therapy, but also permits NIR fluorescence photoacoustic (NIRF/PA) imaging Mechanistic investigation reveals the elicited cell predominantly via necroptosis pathway. Moreover, with liver-targeting moiety enables high-contrast NIRF/PA vivo. This exhibits remarkable ablation cells, enhancing dendritic maturation cytotoxic T recruitment fibrosis. Our study highlights potential type I boosting immunity treatment.

Language: Английский

Citations

0